MIRA Pharmaceuticals Increases Stock Offering Limit
On December 5, 2025, MIRA Pharmaceuticals announced an increase in its stock offering limit by $15.24 million. Key Highlights: Increased stock offering under Sales Agreement with Rodman & Renshaw.New aggregate offering amount is $15,241,591.Previously sold $7,034,658 in shares under prior supplement.Legal opinion on new shares filed as Exhibit 5.1.Original SEC Filing: MIRA PHARMACEUTICALS, INC. [ MIRA ] - 8-K - Dec. 05, 2025DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
On December 5, 2025, MIRA Pharmaceuticals announced an increase in its stock offering limit by $15.24 million.
Key Highlights:
- Increased stock offering under Sales Agreement with Rodman & Renshaw.
- New aggregate offering amount is $15,241,591.
- Previously sold $7,034,658 in shares under prior supplement.
- Legal opinion on new shares filed as Exhibit 5.1.
Original SEC Filing: MIRA PHARMACEUTICALS, INC. [ MIRA ] - 8-K - Dec. 05, 2025
